Saturday, August 18, 2012

Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)